Reply to: “Evidence-based guidelines for tuberculosis screening before biologic treatment initiation” - 19/06/20
Doi : 10.1016/j.jaad.2020.03.039
Anthony P. Fernandez, MD, PhD a, b, ⁎ 
, Ariana Ellis, BS a, c, Urmi Khanna, MD a, AbdulAziz Galadari, MD a
, Ariana Ellis, BS a, c, Urmi Khanna, MD a, AbdulAziz Galadari, MD a a Department of Dermatology, Cleveland Clinic, Cleveland, Ohio
b Department of Pathology, Cleveland Clinic, Cleveland, Ohio
c Northeast Ohio Medical University, Rootstown, Ohio
∗Correspondence to: Anthony P. Fernandez, MD, PhD, Departments of Dermatology and Pathology, Cleveland Clinic, 9500 Euclid Ave, A61, Cleveland, OH 44195Departments of Dermatology and PathologyCleveland Clinic9500 Euclid Ave, A61ClevelandOH44195
Le texte complet de cet article est disponible en PDF.
| Funding sources: None. |
|
| Conflicts of interest: Dr Fernandez receives research support from Mallinckrodt, Corbus, Pfizer, and Novartis and honorarium from AbbVie, Novartis, UCB, and Mallinckrodt for consulting, advisory board participation, and speaking. Drs Khanna and Galadari and Ms Ellis have no conflicts of interest to declare. |
|
| Reprints not available from the authors. |
© 2020
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 83 - N° 1
P. e27-e28 - juillet 2020 Retour au numéro
Article précédent
- Evidenced-based guidelines for tuberculosis screening before biologic treatment initiation
- Payal Shah, Gabriel Rebick, Shirin Bajaj, Ludovic Desvignes, Kristen Lo Sicco
- Recommendations on dermatologic surgery during the COVID-19 pandemic
- Samuel Antranig Der Sarkissian, Leo Kim, Michael Veness, Eleni Yiasemides, Deshan Frank Sebaratnam
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?